Stock Scorecard



Stock Summary for Lantern Pharma Inc (LTRN) - $5.39 as of 5/2/2024 4:53:30 AM EST

Total Score

10 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for LTRN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for LTRN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for LTRN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for LTRN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for LTRN

Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket - Adaptive Biotechnologies ( NASDAQ:ADPT ) , AGBA Group Holding ( NASDAQ:AGBA ) 4/19/2024 9:45:00 AM
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday - Box ( NYSE:BOX ) , American Public Education ( NASDAQ:APEI ) 3/6/2024 4:45:00 PM
UPDATE -- Actuate Therapeutics Announces Poster Presentations at the 2023 AACR Annual Meeting 4/10/2023 2:22:00 PM
Lantern Pharma to Participate at the RHK Capital Disruptive Growth Conference on December 5 at 12:00 p.m. ET 12/2/2022 1:00:00 PM
RHK Capital to Host 2022 Disruptive Growth Conference in NYC on Dec. 5-6 11/22/2022 2:35:00 PM
Lantern Pharma 10% Owner Trades $1.54M In Company Stock - Lantern Pharma ( NASDAQ:LTRN ) 11/10/2022 4:30:00 PM
Lantern Pharma 10% Owner Trades Company's Stock - Lantern Pharma ( NASDAQ:LTRN ) 11/10/2022 4:27:00 PM
Lantern Pharma Recent Insider Activity - Lantern Pharma ( NASDAQ:LTRN ) 11/10/2022 2:25:00 PM
10% Owner At This Health Care Company Sells $1.54M of Stock - Lantern Pharma ( NASDAQ:LTRN ) 11/10/2022 2:25:00 PM
Lantern Pharma to Report Third Quarter 2022 Operating & Financial Results on November 7, 2022 at 4:30 p.m. ET 11/1/2022 6:52:00 AM

Financial Details for LTRN

Company Overview

Ticker LTRN
Company Name Lantern Pharma Inc
Country USA
Description Lantern Pharma Inc., a clinical-stage biotechnology company, focuses on developing precision cancer therapies using artificial intelligence, genomics, and machine learning. The company is headquartered in Dallas, Texas.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 6/13/2024

Stock Price History

Last Day Price 5.39
Last Day Price Updated 5/2/2024 4:53:30 AM EST
Last Day Volume 123,183
Average Daily Volume 259,680
52-Week High 11.99
52-Week Low 2.38
Last Price to 52 Week Low 126.47%

Valuation Measures

Trailing PE N/A
Industry PE 67.75
Sector PE 54.22
5-Year Average PE -5.57
Free Cash Flow Ratio 1.40
Industry Free Cash Flow Ratio 13.67
Sector Free Cash Flow Ratio 32.33
Current Ratio Most Recent Quarter 16.18
Total Cash Per Share 3.85
Book Value Per Share Most Recent Quarter 3.82
Price to Book Ratio 1.68
Industry Price to Book Ratio 5.72
Sector Price to Book Ratio 22.23
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 5.44
Sector Price to Sales Ratio Twelve Trailing Months 5.15

Share Statistics

Total Shares Outstanding 10,741,300
Market Capitalization 57,895,607
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -11.94%
Reported EPS 12 Trailing Months -1.47
Reported EPS Past Year 0.00
Reported EPS Prior Year -1.48
Net Income Twelve Trailing Months -15,962,000
Net Income Past Year -15,962,000
Net Income Prior Year -14,259,946
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 41,302,672
Total Cash Past Year 41,302,672
Total Cash Prior Year 55,196,085
Net Cash Position Most Recent Quarter 41,302,672
Net Cash Position Past Year 41,302,672
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 40,907,934
Total Stockholder Equity Prior Year 56,038,024
Total Stockholder Equity Most Recent Quarter 40,907,934

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.60
MACD Signal -0.45
20-Day Bollinger Lower Band 1.59
20-Day Bollinger Middle Band 5.62
20-Day Bollinger Upper Band 9.65
Beta 1.40
RSI 39.51
50-Day SMA 4.87
200-Day SMA 8.99

System

Modified 5/2/2024 4:53:31 AM EST